Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation.

Yosefy C, Pery M, Nevzorov R, Piltz X, Osherov A, Jafari J, Beeri R, Gallego-Colon E, Daum A, Khalameizer V.

Clin Cardiol. 2020 Jan;43(1):71-77. doi: 10.1002/clc.23292. Epub 2019 Nov 22.

2.

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia.

Jafari J, Daum A, Hamed JA, Osherov A, Orlov Y, Yosefy C, Gallego-Colon E.

Biomedicines. 2019 Oct 7;7(4). pii: E79. doi: 10.3390/biomedicines7040079.

3.

Reduction in operator radiation exposure during transradial coronary procedures using a simple lead rectangle.

Osherov AB, Bruoha S, Laish Farkash A, Paul G, Orlov I, Katz A, Jafari J.

Heliyon. 2017 Feb 24;3(2):e00254. doi: 10.1016/j.heliyon.2017.e00254. eCollection 2017 Feb.

4.

Distal coronary embolization following acute myocardial infarction increases early infarct size and late left ventricular wall thinning in a porcine model.

Thomas RM, Lim SY, Qiang B, Osherov AB, Ghugre NR, Noyan H, Qi X, Wolff R, Ladouceur-Wodzak M, Berk TA, Butany J, Husain M, Wright GA, Strauss BH.

J Cardiovasc Magn Reson. 2015 Dec 1;17:106. doi: 10.1186/s12968-015-0197-y.

5.

Site localization of painful lesions during radiofrequency ablation of pulmonary veins using circular multi-electrode catheters.

Laish-Farkash A, Katz A, Cohen O, Osherov A, Bruocha S, Khalameizer V.

J Interv Card Electrophysiol. 2016 Jan;45(1):63-9. doi: 10.1007/s10840-015-0065-6. Epub 2015 Nov 9.

PMID:
26552799
6.

Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.

Qiang B, Lim SY, Lekas M, Kuliszewski MA, Wolff R, Osherov AB, Rudenko D, Leong-Poi H, Noyan H, Husain M, Tran K, Tryggvason K, Hedin U, Tran-Lundmark K, Strauss BH.

Can J Cardiol. 2014 Nov;30(11):1444-51. doi: 10.1016/j.cjca.2014.06.003. Epub 2014 Jun 12.

PMID:
25249499
7.

Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.

Gotha L, Lim SY, Osherov AB, Wolff R, Qiang B, Erlich I, Nili N, Pillarisetti S, Chang YT, Tran PK, Tryggvason K, Hedin U, Tran-Lundmark K, Advani SL, Gilbert RE, Strauss BH.

Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H337-45. doi: 10.1152/ajpheart.00654.2013. Epub 2014 May 23.

8.

Anomalous origin of the left internal mammary artery from the aortic arch.

Osherov A, Azhibekov Y, Jafari J, Orlov I.

Int J Cardiol. 2014 Feb 1;171(2):e59-60. doi: 10.1016/j.ijcard.2013.11.108. Epub 2013 Dec 10. No abstract available.

PMID:
24374207
9.

A novel lead attenuator to reduce operator exposure to scattered radiation in transradial coronary procedures.

Osherov AB, Seidelin P, Wolff R, Wright GA, Strauss BH, Robert N.

EuroIntervention. 2013 Oct;9(6):757-60. doi: 10.4244/EIJV9I6A121. No abstract available.

10.

Therapeutic angiogenesis with VEGF164 for facilitation of guidewire crossing in experimental arterial chronic total occlusions.

Teitelbaum AA, Qi X, Osherov AB, Fraser AR, Ladouceur-Wodzak M, Munce N, Qiang B, Weisbrod M, Bierstone D, Erlich I, Sparkes JD, Wright GA, Strauss BH.

EuroIntervention. 2013 Jan 22;8(9):1081-9. doi: 10.4244/EIJV8I9A165.

11.

Characterisation of a novel porcine coronary artery CTO model.

Fefer P, Robert N, Qiang B, Liu G, Munce N, Anderson K, Osherov AB, Ladouceur-Wodzak M, Qi X, Dick A, Weisbrod M, Samuel M, Butany J, Wright G, Strauss BH.

EuroIntervention. 2012 Apr;7(12):1444-52. doi: 10.4244/EIJV7I12A225.

12.

Statin therapy prevents expansive remodeling in venous bypass grafts.

Qiang B, Toma J, Fujii H, Osherov AB, Nili N, Sparkes JD, Fefer P, Samuel M, Butany J, Leong-Poi H, Strauss BH.

Atherosclerosis. 2012 Jul;223(1):106-13. doi: 10.1016/j.atherosclerosis.2012.03.013. Epub 2012 Mar 22.

PMID:
22503825
13.

Clopidogrel Therapy Discontinuation Following Drug Eluting Stent Implantation in Real World Practice in Israel.

Blich M, Shwiri TZ, Petcherski S, Osherov AB, Hammerman H.

Cardiol Res. 2012 Apr;3(2):67-72. doi: 10.4021/cr146w. Epub 2012 Mar 20.

14.

Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.

Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, Gannot S, Samuel M, Weisbrod M, Bierstone D, Sparkes JD, Wright GA, Strauss BH.

J Am Coll Cardiol. 2012 Mar 13;59(11):991-7. doi: 10.1016/j.jacc.2011.12.007.

15.

Collagenase Total Occlusion-1 (CTO-1) trial: a phase I, dose-escalation, safety study.

Strauss BH, Osherov AB, Radhakrishnan S, Mancini GB, Manners A, Sparkes JD, Chisholm RJ.

Circulation. 2012 Jan 24;125(3):522-8. doi: 10.1161/CIRCULATIONAHA.111.063198. Epub 2011 Dec 16.

16.

Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.

Freixa X, Almasood AS, Khan SQ, Wainstein R, Osherov A, Mackie K, Seidelin PH, Džavík V.

Catheter Cardiovasc Interv. 2012 Mar 1;79(4):559-65. doi: 10.1002/ccd.23031. Epub 2011 May 12.

PMID:
21567881
17.

Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy.

Osherov AB, Gotha L, Cheema AN, Qiang B, Strauss BH.

Cardiovasc Res. 2011 Jul 1;91(1):16-26. doi: 10.1093/cvr/cvr012. Epub 2011 Jan 18. Review.

PMID:
21245059
18.

How should I treat severe coronary artery calcification when it is not possible to dilate a balloon or deliver a RotaWire™?

McKenzie DB, Talwar S, Jokhi PP, O'Kane PD, Osherov A, Strauss B, Dahm J.

EuroIntervention. 2011 Jan;6(6):779-83. doi: 10.4244/EIJV6I6A132. No abstract available.

PMID:
21205605
19.

Inhibition of intimal hyperplasia after stenting by over-expression of p15: a member of the INK4 family of cyclin-dependent kinase inhibitors.

Segev A, Nili N, Qiang B, Osherov AB, Giordano FJ, Jaffe R, Gauldie J, Sparkes JD, Fraser AR, Ladouceur-Wodzak M, Butany J, Strauss BH.

J Mol Cell Cardiol. 2011 Mar;50(3):417-25. doi: 10.1016/j.yjmcc.2010.11.007. Epub 2010 Nov 21.

PMID:
21081134
20.

Incidence, predictors and outcome of drug-eluting stent thrombosis in real-world practice.

Blich M, Zeidan-Shwiri T, Petcherski S, Osherov A, Hammerman H.

J Invasive Cardiol. 2010 Oct;22(10):461-4.

Supplemental Content

Loading ...
Support Center